Disrupted Neural Regeneration in Dry Eye Secondary to Ankylosing Spondylitis-With a Theoretical Link between Piezo2 Channelopathy and Gateway Reflex, WDR Neurons, and Flare-Ups.

Piezo1 Piezo2 channelopathy Th17/Treg imbalance WDR neurons ankylosing spondylitis autoimmune disease dry eye disease gateway reflex

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
22 Oct 2023
Historique:
received: 24 09 2023
revised: 20 10 2023
accepted: 21 10 2023
medline: 30 10 2023
pubmed: 28 10 2023
entrez: 28 10 2023
Statut: epublish

Résumé

This study aimed at analyzing the corneal neural regeneration in ankylosing spondylitis patients using in vivo corneal confocal microscopy in correlation with Langerhans cell density, morphology, and dry eye parameters. Approximately 24 ankylosing spondylitis subjects and 35 age- and gender-matched control subjects were enrolled. Data analysis showed that all corneal nerve-fiber descriptives were lower in the ankylosing spondylitis group, implicating disrupted neural regeneration. Peripheral Langerhans cell density showed a negative correlation with nerve fiber descriptions. A negative correlation between tear film break-up time and corneal nerve fiber total branch density was detected. The potential role of somatosensory terminal Piezo2 channelopathy in the pathogenesis of dry eye disease and ankylosing spondylitis is highlighted in our study, exposing the neuroimmunological link between these diseases. We hypothesized earlier that spinal neuroimmune-induced sensitization due to this somatosensory terminal primary damage could lead to Langerhans cell activation in the cornea, in association with downregulated Piezo1 channels on these cells. This activation could lead to a Th17/Treg imbalance in dry eye secondary to ankylosing spondylitis. Hence, the corneal Piezo2 channelopathy-induced impaired Piezo2-Piezo1 crosstalk could explain the disrupted neural regeneration. Moreover, the translation of our findings highlights the link between Piezo2 channelopathy-induced gateway to pathophysiology and the gateway reflex, not to mention the potential role of spinal wide dynamic range neurons in the evolution of neuropathic pain and the flare-ups in ankylosing spondylitis and dry eye disease.

Identifiants

pubmed: 37895134
pii: ijms242015455
doi: 10.3390/ijms242015455
pmc: PMC10607705
pii:
doi:

Substances chimiques

PIEZO2 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Antioxidants (Basel). 2020 Mar 05;9(3):
pubmed: 32150878
Diabetes Care. 2013 Sep;36(9):2748-55
pubmed: 23579181
J Rheumatol. 1994 Dec;21(12):2286-91
pubmed: 7699630
Neurosci Lett. 2015 Jun 2;596:33-50
pubmed: 25617478
Biochim Biophys Acta. 2015 May;1853(5):1010-21
pubmed: 25662098
Invest Ophthalmol Vis Sci. 2009 Jan;50(1):263-72
pubmed: 18775867
Int J Appl Basic Med Res. 2018 Oct-Dec;8(4):266-268
pubmed: 30598918
Rheumatol Int. 2021 Mar;41(3):595-603
pubmed: 33502552
Int J Environ Res Public Health. 2022 Dec 05;19(23):
pubmed: 36498369
Cell. 2012 Feb 3;148(3):447-57
pubmed: 22304915
Prog Biophys Mol Biol. 2017 Nov;130(Pt B):244-253
pubmed: 28778608
Cornea. 2022 Jul 1;41(7):879-885
pubmed: 35349500
Ocul Surf. 2018 Jan;16(1):31-44
pubmed: 29031645
Eur J Pharm Biopharm. 2022 Apr;173:73-91
pubmed: 35227856
Clin Ther. 2021 Sep;43(9):1457-1475
pubmed: 33965237
Neuron. 2019 Apr 17;102(2):373-389.e6
pubmed: 30819546
Rheumatol Int. 2009 Jul;29(9):1031-40
pubmed: 19153738
Nat Genet. 2011 Jul 10;43(8):761-7
pubmed: 21743469
Biochem J. 2004 Oct 1;383(Pt 1):129-38
pubmed: 15198637
Exp Eye Res. 2022 Feb;215:108851
pubmed: 34896307
Sci Signal. 2015 Feb 10;8(363):ra15
pubmed: 25670203
Arthritis Rheum. 2007 Jan;56(1):224-33
pubmed: 17195226
J Leukoc Biol. 2023 Apr 11;:
pubmed: 37040589
Ann Rheum Dis. 2023 Apr;82(4):533-545
pubmed: 36543525
Innate Immun. 2014 Jul;20(5):471-7
pubmed: 23960273
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2847-56
pubmed: 16799024
Elife. 2019 Jul 10;8:
pubmed: 31290742
Int J Mol Sci. 2023 Apr 19;24(8):
pubmed: 37108693
Lancet. 2007 Apr 21;369(9570):1379-1390
pubmed: 17448825
RMD Open. 2021 Feb;7(1):
pubmed: 33547227
Arthritis Rheum. 2012 May;64(5):1420-9
pubmed: 22144400
Life (Basel). 2021 May 14;11(5):
pubmed: 34069060
Immunology. 2020 Oct;161(2):94-102
pubmed: 32696457
Prog Retin Eye Res. 2012 May;31(3):271-85
pubmed: 22426080
J Clin Immunol. 2013 Jan;33(1):151-61
pubmed: 22926407
Int J Mol Sci. 2023 Jun 26;24(13):
pubmed: 37445856
Sci Transl Med. 2018 Oct 10;10(462):
pubmed: 30305456
World J Diabetes. 2018 Dec 15;9(12):220-225
pubmed: 30588283
Reumatologia. 2020;58(5):297-311
pubmed: 33227082
Nat Commun. 2013;4:1682
pubmed: 23575686
Front Physiol. 2021 Jul 15;12:644929
pubmed: 34335288
Graefes Arch Clin Exp Ophthalmol. 2005 Oct;243(10):1056-61
pubmed: 15856272
Mov Disord. 2017 Aug;32(8):1256-1258
pubmed: 28582598
J Immunol. 2003 Aug 15;171(4):2057-65
pubmed: 12902511
Nat Rev Immunol. 2010 Jul;10(7):490-500
pubmed: 20559327
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5525-5530
pubmed: 30480740
ACS Appl Mater Interfaces. 2017 May 31;9(21):17663-17680
pubmed: 28485910
Front Pharmacol. 2021 Nov 30;12:764396
pubmed: 34916942
Musculoskelet Sci Pract. 2021 Feb;51:102304
pubmed: 33227676
BMC Sports Sci Med Rehabil. 2021 Nov 25;13(1):149
pubmed: 34823577
Lancet. 1973 Apr 28;1(7809):904-7
pubmed: 4123836
Biomolecules. 2022 Aug 31;12(9):
pubmed: 36139045
Eye (Lond). 2011 Apr;25(4):502-10
pubmed: 21252949
Science. 2023 Jan 13;379(6628):201-206
pubmed: 36634173
Invest Ophthalmol Vis Sci. 2021 Jan 4;62(1):2
pubmed: 33393968
Arthritis Rheum. 1984 Apr;27(4):361-8
pubmed: 6231933
J Neurosci. 2020 Nov 18;40(47):8976-8993
pubmed: 33055278
Molecules. 2017 Jan 14;22(1):
pubmed: 28098832
iScience. 2020 Nov 07;23(12):101784
pubmed: 33294792
Nature. 2002 Dec 19-26;420(6917):853-9
pubmed: 12490958
Int J Mol Sci. 2022 Oct 08;23(19):
pubmed: 36233237
Metabolites. 2022 Sep 13;12(9):
pubmed: 36144262
Biomedicines. 2023 Mar 17;11(3):
pubmed: 36979911
Neuroscientist. 2023 Aug;29(4):421-444
pubmed: 35414308
Front Pharmacol. 2021 Oct 14;12:738316
pubmed: 34721027
Lancet Neurol. 2023 Jan;22(1):24-25
pubmed: 36517162
J Biol Chem. 2003 Oct 17;278(42):40764-70
pubmed: 12904296
Pain Med. 2022 Jul 1;23(7):1283-1298
pubmed: 34718773
Int Immunol. 2022 Jan 22;34(2):59-65
pubmed: 33978730
Clin Exp Hypertens. 2023 Dec 31;45(1):2156529
pubmed: 36524421
Innate Immun. 2013;19(4):348-54
pubmed: 23204037
Arch Ophthalmol. 2006 Apr;124(4):462-8
pubmed: 16606870
Rheumatol Int. 2019 Dec;39(12):2043-2051
pubmed: 31435752
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES7-DES12
pubmed: 30481800
Elife. 2022 Oct 24;11:
pubmed: 36278870
Ocul Surf. 2007 Apr;5(2):93-107
pubmed: 17508117
Sci Rep. 2017 Dec 18;7(1):17696
pubmed: 29255201
Clin Exp Rheumatol. 2012 Jul-Aug;30(4):469-75
pubmed: 22510234
Diagnostics (Basel). 2022 Dec 23;13(1):
pubmed: 36611338
Int J Mol Sci. 2022 Aug 12;23(16):
pubmed: 36012312
Arch Ophthalmol. 2000 May;118(5):615-21
pubmed: 10815152
Autoimmun Rev. 2021 Nov;20(11):102933
pubmed: 34509656
J Mol Neurosci. 2022 Aug;72(8):1598-1608
pubmed: 35507012
Front Immunol. 2021 Nov 02;12:744396
pubmed: 34795665
Brain Sci. 2021 Jan 15;11(1):
pubmed: 33467407
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Int J Mol Sci. 2022 Sep 21;23(19):
pubmed: 36232420
Cell Rep. 2014 Jul 10;8(1):272-83
pubmed: 25001284
Cornea. 2019 Oct;38(10):1253-1258
pubmed: 31306286
Ocul Surf. 2021 Oct;22:135-142
pubmed: 34407488
Cells. 2021 Jul 23;10(8):
pubmed: 34440637
Nat Commun. 2023 Apr 29;14(1):2479
pubmed: 37120427
Nat Neurosci. 2015 Dec;18(12):1756-62
pubmed: 26551544
J Funct Morphol Kinesiol. 2022 May 27;7(2):
pubmed: 35736014
Am J Physiol Cell Physiol. 2019 Jan 1;316(1):C92-C103
pubmed: 30427721
Front Physiol. 2022 Sep 14;13:1003999
pubmed: 36187790
Clin Rheumatol. 2018 Nov;37(11):3077-3086
pubmed: 29713968
Arthritis Res Ther. 2012 May 08;14(3):R108
pubmed: 22569245
Science. 1965 Nov 19;150(3699):971-9
pubmed: 5320816
Life (Basel). 2023 Feb 27;13(3):
pubmed: 36983813
Int J Cosmet Sci. 2023 Oct;45(5):604-611
pubmed: 37170671
Lancet Neurol. 2018 Sep;17(9):744
pubmed: 28964703
Front Endocrinol (Lausanne). 2022 Oct 12;13:891575
pubmed: 36313738
J Ophthalmol. 2015;2015:543835
pubmed: 25893112

Auteurs

Balázs Sonkodi (B)

Department of Health Sciences and Sport Medicine, Hungarian University of Sports Science, 1123 Budapest, Hungary.

László Marsovszky (L)

Department of Ophthalmology, Semmelweis University, 1085 Budapest, Hungary.

Anita Csorba (A)

Department of Ophthalmology, Semmelweis University, 1085 Budapest, Hungary.

Attila Balog (A)

Department of Rheumatology and Immunology, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.

Bence Kopper (B)

Faculty of Kinesiology, Hungarian University of Sports Science, 1123 Budapest, Hungary.

Anikó Keller-Pintér (A)

Department of Biochemistry, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.

Zoltán Zsolt Nagy (ZZ)

Department of Ophthalmology, Semmelweis University, 1085 Budapest, Hungary.

Miklós D Resch (MD)

Department of Ophthalmology, Semmelweis University, 1085 Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH